OUR TEAM
Pharma Connect Navigator combines technology with ongoing guidance from experienced professionals across CMC, pharmaceutical development, manufacturing, product strategy, and company building.
PCN is founder-led and supported by advisors who help shape the platform, its direction, and the way it approaches CDMO sourcing and manufacturing-partner selection. Our CMC Partners & Advisors also work directly with biotechnology and pharmaceutical sponsors when additional CMC guidance is needed.
Founder & CEO
Nicholas Denzer founded Pharma Connect Navigator and leads the company's product vision, strategy, partnerships, customer discovery, and commercialization.
Focus: Product strategy, partnerships, customer discovery, and company development.
PCN's CMC Partners & Advisors provide ongoing guidance on the platform while also working directly with biotechnology and pharmaceutical teams that need additional CMC support. Their perspective helps shape PCN's CDMO sourcing workflows, product features, and approach to manufacturing-partner evaluation.
CMC Partner & Advisor
Rowena Choudrie brings more than three decades of experience across CMC leadership, pharmaceutical development, manufacturing, technical operations, technology transfer, and program management.
At PCN, she supports sponsors seeking CMC guidance and advises on platform direction, CDMO evaluation, and sourcing workflows.
Focus: CMC strategy, pharmaceutical development, CDMO selection, technology transfer, and technical operations.
CMC Partner & Advisor
John A. Laino is a life-sciences operations executive and founder of Execucell Advisors with more than 20 years of experience across biopharmaceutical manufacturing, CMC operations, supply chain, external manufacturing, and CDMO management.
At PCN, he supports sponsors seeking CMC guidance and advises on sourcing, supplier evaluation, and platform development.
Focus: CDMO sourcing, manufacturing operations, supplier strategy, CMC execution, and supply chain.
Product & Industry Advisor
Michael Denzer is a biopharmaceutical product-development and engineering leader with experience across combination products, drug delivery, manufacturing, commercialization, and external partnerships.
He advises PCN on product strategy, platform features, company direction, and the product roadmap.
Focus: Product strategy, pharmaceutical development, manufacturing workflows, and platform roadmap.
Executive Leadership Advisor
Bill Goodwin is an entrepreneur, advisor, investor, and founder with more than three decades of experience helping companies build, position, launch, and grow.
He advises on executive leadership, company strategy, positioning, and strategic relationships.
Focus: Executive leadership, company strategy, positioning, and strategic relationships.
Executive Leadership Advisor
Managing Partner, Garden State Venture Partners
Shawn Hill is an investor, founder, advisor, and Managing Partner of Garden State Venture Partners.
He advises on executive leadership, company strategy, venture development, scaling, and building an early-stage company.
Focus: Executive leadership, venture strategy, scaling, and company building.
Experienced CMC Guidance
Software can make CDMO sourcing more structured, but it cannot replace experienced CMC judgment.
When additional support is needed, PCN can connect biotechnology and pharmaceutical sponsors with CMC Partners & Advisors Rowena Choudrie and John A. Laino for guidance around CMC strategy, CDMO selection, manufacturing readiness, technology transfer, and program execution.
Their ongoing involvement also helps keep PCN grounded in how sponsors evaluate and work with manufacturing partners in practice.
Built With Industry Guidance
PCN combines structured technology with experienced CMC, pharmaceutical, and business guidance to make CDMO sourcing more efficient without removing human judgment from the process.
Structured Data, CDMO Matching Technology, CMC Expertise, Pharmaceutical Experience, and Executive Guidance.
The goal is not to replace experienced professionals. It is to give them better infrastructure to work with.
Venture Backing
Pharma Connect Navigator is a portfolio company of the Rowan Innovation Venture Fund, managed by Garden State Venture Partners.
The relationship gives PCN access to experienced investors, operators, advisors, and a broader venture ecosystem as the company continues to develop.
